Acute infection and neurological disease by bovine herpesvirus type-5 (BHV-5): Rabbits as an experimental model

Rabbits are susceptible to bovine herpesvirus type 5 (BHV-5) infection and often develop an acute and fatal neurological disease upon intranasal inoculation. The kinetics of viral infection of the central nervous system (CNS) was investigated by testing serial brain sections for infectivity at intervals after virus inoculation. The virus was first detected in the main olfactory bulb at 48h, followed by the olfactory cortex at 48/72h. At 72/96h infectivity was also detected in the trigeminal ganglia, pons and cerebral cortex. Two experiments were conducted to investigate the role of the olfactory system in the invasion of the rabbits' CNS by BHV-5. In the first experiment, rabbits were inoculated with two BHV-5 isolates in the conjunctival sac. Rabbits inoculated by this route developed the neurological disease, yet with a reduced frequency and delayed clinical course. In a second experiment, twelve rabbits were submitted to surgical removal of the olfactory bulb and subsequently inoculated intranasally with BHV-5. Eleven out of 12 (91.6%) of the control rabbits developed the disease, against four out of 12 (33.3%) of the animals lacking the olfactory bulb. These results suggest that the olfactory system is the main pathway utilized by BHV-5 to reach the CNS of rabbits after intranasal inoculation. Nevertheless, the development of neurological infection in rabbits inoculated in the conjunctival sac and in rabbits lacking the olfactory bulb indicate that BHV-5 may utilize an alternative route to invade the CNS, probably the sensory and autonomic fibers of the trigeminal nerve. The effects of immunization with homologous (BHV-5) and heterologous (BHV-1) strains in prevention of neurological disease by BHV-5 were investigated. Five out of 10 rabbits (50%) immunized with BHV-5 showed mild and transient neurological signs and one died upon challenge. Interestingly, the degree of protection against BHV-5 challenge was higher in rabbits immunized with BHV-1: only two rabbits showed transient neurological signs and subsequently recovered. Thus, prevention of neurological disease by BHV-5 in rabbits may be achieved by immunization with either BHV-5 or BHV-1, likely reflecting the extensive serological cross-reactivity between these viruses. Further studies in rabbits may help in understanding the pathogenesis and immune response to BHV-5 infection.

Bovine herpesvirus type 5 (BHV-5); meningo-encephalitis; rabbits; experimental model